US Stock MarketDetailed Quotes

BCRX BioCryst Pharmaceuticals

Watchlist
  • 10.080
  • -0.190-1.85%
Close May 7 16:00 ET
  • 10.080
  • 0.0000.00%
Pre 05:11 ET
2.11BMarket Cap-38.77P/E (TTM)

BioCryst Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
48.74%-27.52M
45.32%-52.02M
41.55%-5.21M
141.44%8.25M
92.73%-1.37M
-12.99%-53.68M
41.22%-95.14M
62.61%-8.92M
38.67%-19.9M
32.22%-18.81M
Net income from continuing operations
100.09%32K
60.77%-88.88M
56.59%-26.8M
61.18%-14.03M
83.17%-12.67M
33.66%-35.38M
8.33%-226.54M
13.71%-61.73M
14.98%-36.15M
-27.98%-75.33M
Operating gains losses
----
----
----
----
----
----
--29.02M
--0
--0
----
Depreciation and amortization
8.17%331K
-24.71%1.25M
-26.95%309K
-25.95%311K
-21.38%320K
-24.44%306K
15.17%1.66M
6.82%423K
7.97%420K
21.49%407K
Other non cash items
-26.61%14.27M
-20.03%68.96M
-22.83%15.39M
-34.30%14.53M
-17.36%19.6M
-4.95%19.44M
-13.65%86.23M
-55.42%19.94M
20.22%22.11M
33.85%23.72M
Change In working capital
-28.05%-62.13M
-169.38%-87.28M
-162.60%-11.33M
43.62%-9.13M
-175.38%-18.3M
-75.44%-48.52M
45.03%-32.4M
253.94%18.1M
9.64%-16.2M
-301.58%-6.64M
-Change in receivables
-264.34%-13.99M
-272.40%-22.7M
-145.66%-7.3M
-186.31%-3.32M
8.25%-8.25M
-290.14%-3.84M
71.61%-6.1M
61.14%-2.97M
358.96%3.84M
-69.73%-8.99M
-Change in inventory
28.69%-870K
-187.17%-4.16M
-338.48%-2.16M
55.11%-1.52M
-17.71%739K
-1,031.30%-1.22M
88.33%-1.45M
178.19%907K
7.84%-3.39M
112.41%898K
-Change in prepaid assets
-111.93%-132K
128.72%1.96M
-19.15%574K
75.75%-1.47M
64.16%1.75M
143.42%1.11M
-164.03%-6.82M
148.93%710K
-7,273.17%-6.05M
-16.30%1.06M
-Change in payables and accrued expense
-5.78%-47.14M
-271.17%-62.38M
-112.31%-2.45M
69.45%-2.83M
-6,567.02%-12.53M
-63.70%-44.57M
24.84%-16.81M
1,964.17%19.87M
27.80%-9.26M
-101.30%-188K
-Change in other working capital
----
----
----
----
----
----
-1,028.44%-1.23M
4.34%-419K
-1,041.26%-1.35M
413.51%570K
Cash from discontinued investing activities
Operating cash flow
48.74%-27.52M
45.32%-52.02M
41.55%-5.21M
141.44%8.25M
92.73%-1.37M
-12.99%-53.68M
41.22%-95.14M
62.61%-8.92M
38.67%-19.9M
32.22%-18.81M
Investing cash flow
Cash flow from continuing investing activities
-5.78%27.1M
140.00%52.59M
162.50%17.8M
-63.28%8.49M
87.13%-2.45M
126.85%28.76M
-2.54%-131.5M
-136.87%-28.47M
133.24%23.12M
80.46%-19.04M
Net PPE purchase and sale
39.15%-143K
48.15%-1.12M
-21.84%-675K
94.02%-59K
66.81%-155K
-46.88%-235K
-60.47%-2.17M
-5.32%-554K
-464.00%-987K
-91.39%-467K
Net investment purchase and sale
-6.05%27.24M
141.53%53.72M
166.16%18.47M
-64.54%8.55M
87.65%-2.29M
127.11%28.99M
-1.93%-129.33M
-135.91%-27.92M
134.75%24.11M
80.90%-18.57M
Cash from discontinued investing activities
Investing cash flow
-5.78%27.1M
140.00%52.59M
162.50%17.8M
-63.28%8.49M
87.13%-2.45M
126.85%28.76M
-2.54%-131.5M
-136.87%-28.47M
133.24%23.12M
80.46%-19.04M
Financing cash flow
Cash flow from continuing financing activities
150.48%529K
-117.73%-5.76M
-26.73%-4.02M
4.00%1.27M
-106.70%-1.97M
-120.64%-1.05M
-63.10%32.49M
-175.57%-3.17M
-98.40%1.23M
19,870.07%29.36M
Net issuance payments of debt
-32.31%-516K
-102.92%-1.7M
69.44%-356K
---556K
-100.68%-402K
---390K
-20.10%58.38M
---1.17M
--0
--59.55M
Net common stock issuance
-45.45%6K
-90.06%34K
-96.00%5K
-45.45%6K
-94.17%12K
--11K
80.00%342K
--125K
--11K
--206K
Proceeds from stock option exercised by employees
42.18%2.39M
-58.71%3.44M
-1,602.56%-586K
41.26%2.09M
-84.90%264K
-66.89%1.68M
-43.52%8.34M
-99.03%39K
-54.63%1.48M
1,089.12%1.75M
Net other financing activities
42.51%-1.35M
78.21%-7.54M
-41.99%-3.08M
0.38%-261K
---1.84M
---2.35M
---34.58M
---2.17M
---262K
----
Cash from discontinued financing activities
Financing cash flow
150.48%529K
-117.73%-5.76M
-26.73%-4.02M
4.00%1.27M
-106.70%-1.97M
-120.64%-1.05M
-63.10%32.49M
-175.57%-3.17M
-98.40%1.23M
19,870.07%29.36M
Net cash flow
Beginning cash position
-5.45%106.32M
-63.28%112.45M
-35.04%99.06M
-45.73%80.21M
-45.00%86.13M
-63.28%112.45M
-39.69%306.24M
-38.60%152.49M
-46.07%147.79M
-60.74%156.6M
Current changes in cash
100.41%107K
97.33%-5.19M
121.11%8.56M
304.95%18.01M
31.91%-5.78M
82.63%-25.98M
3.91%-194.15M
-170.47%-40.56M
117.33%4.45M
93.21%-8.49M
Effect of exchange rate changes
232.65%451K
-358.56%-936K
-349.81%-1.3M
236.36%851K
54.89%-143K
-254.17%-340K
-36.04%362K
57.70%522K
1,907.14%253K
-251.67%-317K
End cash Position
24.09%106.88M
-5.45%106.32M
-5.45%106.32M
-35.04%99.06M
-45.73%80.21M
-45.00%86.13M
-63.28%112.45M
-63.28%112.45M
-38.60%152.49M
-46.07%147.79M
Free cash flow
48.70%-27.66M
45.39%-53.14M
37.84%-5.89M
139.20%8.19M
92.10%-1.52M
-13.10%-53.92M
40.37%-97.31M
61.14%-9.47M
35.98%-20.88M
31.14%-19.28M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 48.74%-27.52M45.32%-52.02M41.55%-5.21M141.44%8.25M92.73%-1.37M-12.99%-53.68M41.22%-95.14M62.61%-8.92M38.67%-19.9M32.22%-18.81M
Net income from continuing operations 100.09%32K60.77%-88.88M56.59%-26.8M61.18%-14.03M83.17%-12.67M33.66%-35.38M8.33%-226.54M13.71%-61.73M14.98%-36.15M-27.98%-75.33M
Operating gains losses --------------------------29.02M--0--0----
Depreciation and amortization 8.17%331K-24.71%1.25M-26.95%309K-25.95%311K-21.38%320K-24.44%306K15.17%1.66M6.82%423K7.97%420K21.49%407K
Other non cash items -26.61%14.27M-20.03%68.96M-22.83%15.39M-34.30%14.53M-17.36%19.6M-4.95%19.44M-13.65%86.23M-55.42%19.94M20.22%22.11M33.85%23.72M
Change In working capital -28.05%-62.13M-169.38%-87.28M-162.60%-11.33M43.62%-9.13M-175.38%-18.3M-75.44%-48.52M45.03%-32.4M253.94%18.1M9.64%-16.2M-301.58%-6.64M
-Change in receivables -264.34%-13.99M-272.40%-22.7M-145.66%-7.3M-186.31%-3.32M8.25%-8.25M-290.14%-3.84M71.61%-6.1M61.14%-2.97M358.96%3.84M-69.73%-8.99M
-Change in inventory 28.69%-870K-187.17%-4.16M-338.48%-2.16M55.11%-1.52M-17.71%739K-1,031.30%-1.22M88.33%-1.45M178.19%907K7.84%-3.39M112.41%898K
-Change in prepaid assets -111.93%-132K128.72%1.96M-19.15%574K75.75%-1.47M64.16%1.75M143.42%1.11M-164.03%-6.82M148.93%710K-7,273.17%-6.05M-16.30%1.06M
-Change in payables and accrued expense -5.78%-47.14M-271.17%-62.38M-112.31%-2.45M69.45%-2.83M-6,567.02%-12.53M-63.70%-44.57M24.84%-16.81M1,964.17%19.87M27.80%-9.26M-101.30%-188K
-Change in other working capital -------------------------1,028.44%-1.23M4.34%-419K-1,041.26%-1.35M413.51%570K
Cash from discontinued investing activities
Operating cash flow 48.74%-27.52M45.32%-52.02M41.55%-5.21M141.44%8.25M92.73%-1.37M-12.99%-53.68M41.22%-95.14M62.61%-8.92M38.67%-19.9M32.22%-18.81M
Investing cash flow
Cash flow from continuing investing activities -5.78%27.1M140.00%52.59M162.50%17.8M-63.28%8.49M87.13%-2.45M126.85%28.76M-2.54%-131.5M-136.87%-28.47M133.24%23.12M80.46%-19.04M
Net PPE purchase and sale 39.15%-143K48.15%-1.12M-21.84%-675K94.02%-59K66.81%-155K-46.88%-235K-60.47%-2.17M-5.32%-554K-464.00%-987K-91.39%-467K
Net investment purchase and sale -6.05%27.24M141.53%53.72M166.16%18.47M-64.54%8.55M87.65%-2.29M127.11%28.99M-1.93%-129.33M-135.91%-27.92M134.75%24.11M80.90%-18.57M
Cash from discontinued investing activities
Investing cash flow -5.78%27.1M140.00%52.59M162.50%17.8M-63.28%8.49M87.13%-2.45M126.85%28.76M-2.54%-131.5M-136.87%-28.47M133.24%23.12M80.46%-19.04M
Financing cash flow
Cash flow from continuing financing activities 150.48%529K-117.73%-5.76M-26.73%-4.02M4.00%1.27M-106.70%-1.97M-120.64%-1.05M-63.10%32.49M-175.57%-3.17M-98.40%1.23M19,870.07%29.36M
Net issuance payments of debt -32.31%-516K-102.92%-1.7M69.44%-356K---556K-100.68%-402K---390K-20.10%58.38M---1.17M--0--59.55M
Net common stock issuance -45.45%6K-90.06%34K-96.00%5K-45.45%6K-94.17%12K--11K80.00%342K--125K--11K--206K
Proceeds from stock option exercised by employees 42.18%2.39M-58.71%3.44M-1,602.56%-586K41.26%2.09M-84.90%264K-66.89%1.68M-43.52%8.34M-99.03%39K-54.63%1.48M1,089.12%1.75M
Net other financing activities 42.51%-1.35M78.21%-7.54M-41.99%-3.08M0.38%-261K---1.84M---2.35M---34.58M---2.17M---262K----
Cash from discontinued financing activities
Financing cash flow 150.48%529K-117.73%-5.76M-26.73%-4.02M4.00%1.27M-106.70%-1.97M-120.64%-1.05M-63.10%32.49M-175.57%-3.17M-98.40%1.23M19,870.07%29.36M
Net cash flow
Beginning cash position -5.45%106.32M-63.28%112.45M-35.04%99.06M-45.73%80.21M-45.00%86.13M-63.28%112.45M-39.69%306.24M-38.60%152.49M-46.07%147.79M-60.74%156.6M
Current changes in cash 100.41%107K97.33%-5.19M121.11%8.56M304.95%18.01M31.91%-5.78M82.63%-25.98M3.91%-194.15M-170.47%-40.56M117.33%4.45M93.21%-8.49M
Effect of exchange rate changes 232.65%451K-358.56%-936K-349.81%-1.3M236.36%851K54.89%-143K-254.17%-340K-36.04%362K57.70%522K1,907.14%253K-251.67%-317K
End cash Position 24.09%106.88M-5.45%106.32M-5.45%106.32M-35.04%99.06M-45.73%80.21M-45.00%86.13M-63.28%112.45M-63.28%112.45M-38.60%152.49M-46.07%147.79M
Free cash flow 48.70%-27.66M45.39%-53.14M37.84%-5.89M139.20%8.19M92.10%-1.52M-13.10%-53.92M40.37%-97.31M61.14%-9.47M35.98%-20.88M31.14%-19.28M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Market Insights

U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Disney
DIS
102.090
Qualcomm
QCOM
144.300
NVIDIA
NVDA
117.060
4
ASML Holding
ASML
700.390
5
Broadcom
AVGO
204.810
Log In for the Full List
Unlock Now

Investment Course

Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.

Discussing

Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
MicroStrategy Q4 2024 earnings conference call

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.